Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-27 @ 10:52 AM
Study NCT ID:
NCT04851834
Status:
TERMINATED
Last Update Posted:
2022-12-20
First Post:
2021-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Sponsor:
Xennials Therapeutics Australia Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-08
First Submit QC Date:
None
Study First Post Date:
2021-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-18
Last Update Post Date:
2022-12-20
Last Update Post Date Type:
ACTUAL